Dr. Brandon Bebington

Brandon Bebington is a colorectal surgeon and academic researcher based in South Africa, associated with the University of the Witwatersrand and Wits Donald Gordon Medical Centre. His work centers on colorectal cancer in sub-Saharan Africa, integrating clinical surgery, epidemiology, and translational research. He contributes to collaborative cohorts examining disease patterns, disparities, and outcomes across diverse populations.

His publications highlight a strong focus on colorectal cancer phenotype, early-onset disease, racial and regional disparities, and health system factors influencing diagnosis and treatment. He has advanced the use of supervised machine learning and statistical modeling to predict recurrence, survival, and hospital length of stay, supporting data-driven clinical decision-making in resource-constrained settings.

Recent research extends into biomarker discovery, including transcription factor–based approaches to predict progression from inflammatory bowel disease to colorectal cancer. Across surgical innovation, lifestyle risk assessment, and outcome prediction, his scholarship demonstrates strengths in multidisciplinary collaboration, population-based research, and efforts to tailor precision strategies to African patient populations.